ICOS Corp.’s only approved drug, Cialis, is still gaining market share in the U.S. and around the world, and now it’s about to hit China. ICOS’ partner in Cialis, Eli Lilly &Co., is in charge of marketing and distributing the drug there.
Here’s the story from the China Daily and an alternative link to the Asian Times in Hong Kong:
http://www.chinadaily.com.cn/english/doc/2005-04/11/content_433013.htm
http://www.atimes.com/atimes/China/GD12Ad01.html
By the way, in the U.S., Cialis has grabbed nearly 22 percent of the overall erectile drug market, compared to 67 percent for Viagra, according to the latest figures released this morning. Among new prescriptions, Cialis has 24 percent of the market, compared to Viagra’s 63 percent.
Talk to us
> Give us your news tips.
> Send us a letter to the editor.
> More Herald contact information.